8-K filing — Nuwellis, Inc. (NUWE)
Filed: 2026-08-26 AccNo: 0001140361-26-034367 Size: 5 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Read original at edgarStocks · News reference
Nuwellis Announces Preliminary Q2 Earnings With YoY Q2 Revenue Growth Of 14% And H2 Revenue Growth Of 20%
Management expects to report its financial results for the three and six months ended June 30, 2026, before the open of the U.S. financial markets on August 13th and will host a conference call and webcast beginning at
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 27, 2026, 12:33 PM
- Checked
- Jul 27, 2026, 12:33 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Nuwellis Announces Co-Promotion And Distribution Agreement With Atrility Medical For AtriAmp, Starting With Six-Month Program In Three Territories; Terms Not Disclosed
Read original at benzingaNuwellis Q2 2026 Earnings Call Transcript
Nuwellis (NASDAQ:NUWE) released second-quarter financial results and hosted an earnings call on Thursday. Read the complete transcript below. This content is powered by Benzinga APIs. For comprehensive financial data
Read original at benzingaNuwellis Q2 EPS $(26.64) Misses $(0.68) Estimate, Sales $1.969M Miss $2.415M Estimate
Read original at benzinga